Cargando…

High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients

BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) patients with severe complications have shown comorbidities with cardiovascular-disease, hypertension and type 2 diabetes mellitus; clinical disorders that share the common metabolic alterations of insulin resistance and dyslipidaemia. A hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcántara-Alonso, Estefanía, Molinar-Ramos, Fernando, González-López, Jesús Alberto, Alcántara-Alonso, Viridiana, Muñoz-Pérez, Marco Antonio, Lozano-Nuevo, José Juan, Benítez-Maldonado, Daniel Rabindranath, Mendoza-Portillo, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103772/
https://www.ncbi.nlm.nih.gov/pubmed/34330502
http://dx.doi.org/10.1016/j.clnesp.2021.04.020
_version_ 1783689365180907520
author Alcántara-Alonso, Estefanía
Molinar-Ramos, Fernando
González-López, Jesús Alberto
Alcántara-Alonso, Viridiana
Muñoz-Pérez, Marco Antonio
Lozano-Nuevo, José Juan
Benítez-Maldonado, Daniel Rabindranath
Mendoza-Portillo, Elizabeth
author_facet Alcántara-Alonso, Estefanía
Molinar-Ramos, Fernando
González-López, Jesús Alberto
Alcántara-Alonso, Viridiana
Muñoz-Pérez, Marco Antonio
Lozano-Nuevo, José Juan
Benítez-Maldonado, Daniel Rabindranath
Mendoza-Portillo, Elizabeth
author_sort Alcántara-Alonso, Estefanía
collection PubMed
description BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) patients with severe complications have shown comorbidities with cardiovascular-disease, hypertension and type 2 diabetes mellitus; clinical disorders that share the common metabolic alterations of insulin resistance and dyslipidaemia. A high triglyceride to high density lipoprotein cholesterol (Tg/HDL c) ratio has been associated with reduced insulin sensitivity, metabolic syndrome and adverse cardiovascular events. Our aim in this study was to determine the association between different components of the lipid profile and particularly the Tg/HDL c ratio with severe complications like the requirement of invasive mechanical ventilation in COVID-19 patients. METHODS: We collected demographic, clinical and biochemical data to conduct a cohort study in 43 adult patients with confirmed COVID-19 diagnosis by quantitative polymerase chain reaction (qPCR) at baseline and in the subsequent 15 days. Patients were subjected to a very similar treatment scheme with the JAK1/2 inhibitor ruxolitinib. Descriptive statistics, variable association and logistic regression were applied to identify predictors of disease severity among elements and calculations from the lipid profile. RESULTS: Patients were aged 57 ± 14 years; 55.8% were male from which 75% required hospitalization and 44.2% were female who 58% were hospitalized. The most common comorbidities were type 2 diabetes mellitus (58%) and hypertension (40%). Hospitalized and critical care patients showed lower HDL c blood levels and increased Tg/HDL c ratio than those with outpatient management and mild/asymptomatic COVID-19. Tg/HDL c ratio correlated with variables of disease severity such as lactate dehydrogenase (LDH) levels (r = 0.356; p < 0.05); National Early Warning Score 2 (NEWS 2) (r = 0.495; p < 0.01); quick sequential organ failure assessment (qSOFA) (r = 0.538; p < 0.001); increased need of oxygen support (r = 0.447; p < 0.01) and requirement of mechanical ventilation (r = 0.378; p < 0.05). Tg/HDL c ratio had a negative correlation with partial oxygen saturation/fraction of inspired oxygen (SaO 2/FiO2) ratio (r = −0.332;p < 0.05). Linear regression analysis showed that Tg/HDL c ratio can predict increases in inflammatory factors like LDH (p < 0.01); ferritin (p < 0.01) and D-dimer (p < 0.001). Logistic regression model indicated that ≥7.45 Tg/HDL c ratio predicts requirement of invasive mechanical ventilation (OR 11.815, CI 1.832–76.186, p < 0.01). CONCLUSIONS: The Tg/HDLc ratio can be used as an early biochemical marker of COVID-19 severe prognosis with requirement of invasive mechanical ventilation.
format Online
Article
Text
id pubmed-8103772
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-81037722021-05-10 High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients Alcántara-Alonso, Estefanía Molinar-Ramos, Fernando González-López, Jesús Alberto Alcántara-Alonso, Viridiana Muñoz-Pérez, Marco Antonio Lozano-Nuevo, José Juan Benítez-Maldonado, Daniel Rabindranath Mendoza-Portillo, Elizabeth Clin Nutr ESPEN Original Article BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) patients with severe complications have shown comorbidities with cardiovascular-disease, hypertension and type 2 diabetes mellitus; clinical disorders that share the common metabolic alterations of insulin resistance and dyslipidaemia. A high triglyceride to high density lipoprotein cholesterol (Tg/HDL c) ratio has been associated with reduced insulin sensitivity, metabolic syndrome and adverse cardiovascular events. Our aim in this study was to determine the association between different components of the lipid profile and particularly the Tg/HDL c ratio with severe complications like the requirement of invasive mechanical ventilation in COVID-19 patients. METHODS: We collected demographic, clinical and biochemical data to conduct a cohort study in 43 adult patients with confirmed COVID-19 diagnosis by quantitative polymerase chain reaction (qPCR) at baseline and in the subsequent 15 days. Patients were subjected to a very similar treatment scheme with the JAK1/2 inhibitor ruxolitinib. Descriptive statistics, variable association and logistic regression were applied to identify predictors of disease severity among elements and calculations from the lipid profile. RESULTS: Patients were aged 57 ± 14 years; 55.8% were male from which 75% required hospitalization and 44.2% were female who 58% were hospitalized. The most common comorbidities were type 2 diabetes mellitus (58%) and hypertension (40%). Hospitalized and critical care patients showed lower HDL c blood levels and increased Tg/HDL c ratio than those with outpatient management and mild/asymptomatic COVID-19. Tg/HDL c ratio correlated with variables of disease severity such as lactate dehydrogenase (LDH) levels (r = 0.356; p < 0.05); National Early Warning Score 2 (NEWS 2) (r = 0.495; p < 0.01); quick sequential organ failure assessment (qSOFA) (r = 0.538; p < 0.001); increased need of oxygen support (r = 0.447; p < 0.01) and requirement of mechanical ventilation (r = 0.378; p < 0.05). Tg/HDL c ratio had a negative correlation with partial oxygen saturation/fraction of inspired oxygen (SaO 2/FiO2) ratio (r = −0.332;p < 0.05). Linear regression analysis showed that Tg/HDL c ratio can predict increases in inflammatory factors like LDH (p < 0.01); ferritin (p < 0.01) and D-dimer (p < 0.001). Logistic regression model indicated that ≥7.45 Tg/HDL c ratio predicts requirement of invasive mechanical ventilation (OR 11.815, CI 1.832–76.186, p < 0.01). CONCLUSIONS: The Tg/HDLc ratio can be used as an early biochemical marker of COVID-19 severe prognosis with requirement of invasive mechanical ventilation. European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. 2021-08 2021-05-07 /pmc/articles/PMC8103772/ /pubmed/34330502 http://dx.doi.org/10.1016/j.clnesp.2021.04.020 Text en © 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Alcántara-Alonso, Estefanía
Molinar-Ramos, Fernando
González-López, Jesús Alberto
Alcántara-Alonso, Viridiana
Muñoz-Pérez, Marco Antonio
Lozano-Nuevo, José Juan
Benítez-Maldonado, Daniel Rabindranath
Mendoza-Portillo, Elizabeth
High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients
title High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients
title_full High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients
title_fullStr High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients
title_full_unstemmed High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients
title_short High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients
title_sort high triglyceride to hdl-cholesterol ratio as a biochemical marker of severe outcomes in covid-19 patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103772/
https://www.ncbi.nlm.nih.gov/pubmed/34330502
http://dx.doi.org/10.1016/j.clnesp.2021.04.020
work_keys_str_mv AT alcantaraalonsoestefania hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients
AT molinarramosfernando hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients
AT gonzalezlopezjesusalberto hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients
AT alcantaraalonsoviridiana hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients
AT munozperezmarcoantonio hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients
AT lozanonuevojosejuan hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients
AT benitezmaldonadodanielrabindranath hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients
AT mendozaportilloelizabeth hightriglyceridetohdlcholesterolratioasabiochemicalmarkerofsevereoutcomesincovid19patients